Skip to content
MDD Europe 2020 Placeholder Banner (1)

Welcome to the 4th Microbiome Movement - Drug Development Summit Europe 2020

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Part of the foremost conference series for microbiome researchers in industry, the 4th Microbiome Movement – Drug Development Europe 2020 returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.

Book today to secure your place. 

Hear What Our Customers Say

"As a newcomer to the microbiome field, this conference provided an excellent overview.”

Richard Shanksky
Seres  Therapeutics

“It was a great conference to effectively learn the current trends in microbiome drug development around the world.”

Nanae Izumi
Daiichi Sankyo

Meet Our World-Class Speaker Faculty

Rikke Nielsen

CEO & Founder

Beo Therapeutics

Luc Sterkman

CEO

Caelus Health

Sebastien Guery

Human Microbiome Venture Leader

Dupont Microbiome Venture

Rafael Suarez

Senior Director Emerging Brands, Global Marketing, Gastroenterology & Mirobiome

Ferring Pharmaceuticals

Mike Romanos

CEO

Microbiotica

Tomas de Wouters

CEO & Co-Founder

PharmaBIome

Ken Blount

CSO

Rebiotix

Imke Mulder

Director of Research

4D Pharma

Confirmed Partners for 2020 Include:

Atlantia
Biose Industry
Boston Analytical
CosmosID
Luina Bio
NIZO
ProDigest
Quay Pharma

Other Events In The Series